Syndax Pharmaceuticals
SNDX
SNDX
69 hedge funds and large institutions have $89.1M invested in Syndax Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 21
7% less funds holding
Funds holding: 74 → 69 (-5)
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
Holders
69
Holding in Top 10
1
Calls
$350K
Puts
$50K
Top Buyers
| 1 | +$8.14M | |
| 2 | +$1.34M | |
| 3 | +$524K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$513K |
| 5 |
Renaissance Technologies
New York
|
+$449K |
Top Sellers
| 1 | -$718K | |
| 2 | -$619K | |
| 3 | -$437K | |
| 4 |
BlackRock
New York
|
-$406K |
| 5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$377K |